## The Definitive 2020 Pandemic Genomic Review

### Recent Press Releases

1. **[Ovation Reaches 10,000 GLP-1 Clinicogenomic Patient Milestone, Now Available for Licensing](https://www.ovation.io/ovation-reaches-10000-glp-1-clinicogenomic-patient-milestone-now-available-for-licensing/)**  
   April 21, 2026
2. **[PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in H2 2026](https://www.ovation.io/precisionlife-and-ovation-ink-collaboration-agreement-to-launch-glp-1-stratification-ldt-and-consumer-glp-1-dna-test-in-h2-2026/)**  
   April 15, 2026
3. **[PrecisionLife and Ovation identify first potential genetic biomarkers to quantitatively predict GLP-1 efficacy response](https://www.ovation.io/precisionlife-and-ovation-identify-first-potential-genetic-biomarkers-to-quantitatively-predict-glp-1-efficacy-response/)**  
   February 25, 2026
4. **[PrecisionLife and Ovation Partner to Develop Precision Medicine Test to Inform Reimbursement of GLP-1 Anti-Obesity Drugs](https://www.ovation.io/precisionlife-and-ovation-partner-to-develop-precision-medicine-test-to-inform-reimbursement-of-glp-1-anti-obesity-drugs/)**  
   November 25, 2025

### Related Discussions

- **Ovation and DNAnexus Present at the 2nd Precision Medicine in IBD Summit**  
  Learn about the transformative power of leveraging high-value multiomics data alongside advanced techniques.

- **Linking Genomic and Phenotypic Data to Better Understand the Patient Journey**  
  In partnership with Datavant, we explore how researchers can overcome the challenges posed in genomic research.